Thyroid Nodule Clinical Trial
Official title:
Protein Classifier for Thyroid Indeterminate Nodules: a Multi-center Prospective Clinical Study
| Verified date | July 2020 |
| Source | Zhejiang University |
| Contact | Dingcun Luo |
| Phone | +86057156005600 |
| wlsydxjk[@]163.com | |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
In multi-center, prospective, double-blind cohorts, PCT-DIA/MS protein classifier supported by artificial neural networks will be validated to classify thyroid indeterminate nodules.
| Status | Recruiting |
| Enrollment | 320 |
| Est. completion date | December 31, 2021 |
| Est. primary completion date | July 1, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: 1. Patients with aged 18 to 70 years old; 2. Patients with thyroid nodules who have not been treated with drugs; 3. Patients who were diagnosed as Bethesda III and IV by cytology and pathology before operation; 4. Patients who underwent total / partial thyroidectomy and had histopathological reports of corresponding cellular pathological punctured nodules; 5. Patients voluntarily participate in the study after informed consent. Exclusion Criteria: 1. Patients without operation; 2. Patients with insufficient FNA sample size (judged by the laboratory). |
| Country | Name | City | State |
|---|---|---|---|
| China | Hangzhou First People's Hospital Affiliated to Zhejiang University Medical College | Hangzhou | Zhejiang |
| Lead Sponsor | Collaborator |
|---|---|
| Luo Dingcun |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | protein classifier | classify thyroid indeterminate nodules as Benign or Malignant | immediately after the procedure |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04614389 -
Utility of Contrast-Enhanced Sonography and Shear Wave Elastography
|
N/A | |
| Recruiting |
NCT03295955 -
Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy
|
N/A | |
| Completed |
NCT04647006 -
Comparison of TOETVA and Conventional Thyroidectomy
|
N/A | |
| Not yet recruiting |
NCT06029946 -
B-mode Ultrasound, Sono-Elastography, and Diffusion-weighted Imaging MRI in Thyroid Nodules
|
||
| Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
| Terminated |
NCT01320813 -
Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy
|
N/A | |
| Completed |
NCT00877630 -
Minimal Invasiveness of Endoscopic Thyroidectomy
|
N/A | |
| Completed |
NCT01964508 -
microRNA in Thyroid Cancer
|
||
| Completed |
NCT06306599 -
Ultrasound Operator Influence on Diagnostics With AI for Thyroid Nodules - Clinial Trial
|
N/A | |
| Recruiting |
NCT04730726 -
In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules
|
N/A | |
| Not yet recruiting |
NCT03884140 -
Clinical Diagnostic Approach for Cases of Thyroid Nodules
|
||
| Completed |
NCT04277455 -
Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules
|
N/A | |
| Recruiting |
NCT02225509 -
Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology
|
N/A | |
| Completed |
NCT00552253 -
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
|
N/A | |
| Not yet recruiting |
NCT03700762 -
Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.
|
||
| Enrolling by invitation |
NCT01757834 -
Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules
|
N/A | |
| Completed |
NCT01292044 -
The Role of Elastography in the Diagnosis of Thyroid Nodules
|
N/A | |
| Completed |
NCT00858104 -
Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results
|
Phase 4 | |
| Completed |
NCT00651625 -
Reciprocating Medical Devices - a Study of a New Safety Device
|
N/A | |
| Completed |
NCT05132478 -
The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer
|
N/A |